SphK1-IN-3
SphK1-IN-3 is an effective sphingosine kinase-1 (SphK1) inhibitor. SphK1-IN-3 inhibits SphK1 kinase activity with an IC50 value of 2.48 μM. SphK1-IN-3 can be used for the research of many diseases such as cancer, rheumatoid arthritis, diabetes, asthma, and pulmonary fibrosis[1].
Product Specifications
UNSPSC
12352005
Target
SphK
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sphk1-in-3.html
Solubility
10 mM in DMSO
Smiles
O=[N+](C1=CC=C2NC(C3=C(N4CCOCC4)N(C5=CC=CC=C5)N=C3C)=NC2=C1)[O-]
Molecular Formula
C21H20N6O3
Molecular Weight
404.42
References & Citations
[1]Shadia A. Galal, et al. Design and synthesis of new pyrazolylbenzimidazoles as sphingosine kinase-1 inhibitors. Med Chem Res 30, 1614–1634 (2021) .
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SphK1
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SAPS3 (PPP6R3) (NM_001164160) Human Over-expression Lysate
![Phospho-IRF3 (S386) Recombinant Rabbit Monoclonal Antibody [SU03-28]](https://cdn.genprice.uk/products/992/68dd1c8a061270361ea80d64/imageurl/et1608-22.webp)